Improving the mental health
and well-being of patients
with neuropsychiatric diseases
A new class of therapeutics.
Aya Biosciences is a neuroscience company dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases
We are creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics designed to treat the root causes of neuropsychiatric disorders.
Aya is pursuing a strategy to develop psychedelic and non-psychedelic compounds which we believe will provide multiple treatment options for health care providers and their patients.
We are a team of highly experienced drug developers collaborating with the leading laboratories and innovators in the field to realize our mission to provide innovative new medicines to patients.